Director
Current
Jul 2024 - Present
AeroLeads people directory · profile
Sandy Madigan Email & Phone Number
Director
at
Valora Therapeutics, Inc.
1 work email found
@enlazatx.com
1 phone found area 858
LinkedIn matched
✓ Verified August 2026
4 data sources
Profile completeness 100%
Current company
Role
Director
Location
San Diego County, California, United States
Who is Sandy Madigan? Overview
A concise factual answer block for searchers comparing this professional profile.
Quick answer
Sandy Madigan is listed as Director at Valora Therapeutics, Inc., based in San Diego County, California, United States. AeroLeads shows a work email signal at enlazatx.com, phone signal with area code 858, and a matched LinkedIn profile for Sandy Madigan.
Sandy Madigan previously worked as President & CBO at Enlaza Therapeutics and Managing Partner at Avalon Bioventures I. Sandy Madigan holds B.S., Biochemistry from Stony Brook University.
Company email context
Email format at Valora Therapeutics, Inc.
This section adds company-level context without repeating Sandy Madigan's masked contact details.
{first_initial}{last}@enlazatx.com
86% confidence
AeroLeads found 1 current-domain work email signal for Sandy Madigan. Compare company email patterns before reaching out.
Profile bio
About Sandy Madigan
Sandy brings over 30 years of experience to roles at Avalon Bioventures and Avalon portfolio companies and has a track record of building early-stage companies, licensing technologies, providing strategic direction, and negotiating partnerships and acquisitions. Most recently, Sandy was a founder and CEO of Nerio Therapeutics (sold to Boehringer Ingelheim for $1.3B in July, 2024) and the transacting CEO of Calporta Therapeutics which (acquired by Merck for up to $576M in November, 2019).Sandy performed his post-doctoral training at The Salk Institute for Biological Studies. He received his Ph.D. in genetics and his B.S. in biochemistry from The State University of New York at Stony Brook where, as a graduate student, he was a recipient of the Abrahams Memorial Award bestowed for outstanding potential for basic research.
Listed skills include Biotechnology, Pharmaceutical Industry, Biochemistry, Chemistry, and 17 others.
Current workplace
Sandy Madigan's current company
Company context helps verify the profile and gives searchers a useful next step.
12 roles · 31 years
Sandy Madigan work experience
A career timeline built from the work history available for this profile.
President & Cbo
Enlaza Therapeutics (www.enlazatx.com) is pioneering the field of covalent biologics. These novel classes of protein therapeutics deliver more efficacious and safer treatments for patients. The company’s proprietary War-LockTM platform leverages leading synthetic biology technology for site-specific covalent coupling driven by drug binding. Enlaza is building a pipeline of first-in-class covalent biologics.
Managing Partner
Avalon Bioventures I
Avalon BioVentures is primarily focused on early-stage opportunities. We look to build value by developing companies in our Accelerator which provides management, scientific and operational support to entrepreneurs. www.avalonbioventures.com
Ceo
Ankasa is a clinical-stage company developing strategies to improve tissue healing by exploiting the potential of stem cell re-activation. Our initial product is a proprietary formulation of recombinant human WNT protein with demonstrated superiority for bone formation. The Company is currently enrolling a clinical trial in spinal fusion procedures. The field is lacking a bona fide therapeutic agent with demonstrated superiority to standard of care. Successful development of this product will offer surgeons and patients a new opportunity for faster healing accompanied by solid fusions thereby reducing the rate of revision surgeries and their attendant complications. This is both a direct benefit to an at-risk, aging, patient population, as well as direct savings to the healthcare system.
Chief Executive Officer
Nerio Therapeutics, Inc.
Founder and CEO Nerio Therapuetics. Acquired by Boehringer Ingelheim for up to $1.3B.
Mar 2019 - Jul 2024
Ceo
Calporta Therapeutics
Calporta was acquired by Merck in November, 2019 for up to $576M. Calporta develops selective small molecule agonists of TRPML1, which play a role in lysosomal function by promoting autophagy and lysosomal exocytosis. Calporta’s TRPML1 agonists may have broad potential to treat various lysosomal storage and neurodegenerative disorders, including Alzheimer’s and Parkinson’s disease.
2018 - 2020
~2 yrs
Ceo, Co-Founder
Strategic Enzyme Applications
Jan 2009 - Dec 2012
Vp, Corporate Development
2006 - 2008
~2 yrs
Vp, Corporate Development
2002 - 2005
~3 yrs
Vp, Corporate Development
Ambit Biosciences
2001 - 2002
~1 yr
Vp, Corporate Development
X-Ceptor Therapeutics
1999 - 2001
~2 yrs
Director, Business Development
Sibia Neurosciences
1996 - 1999
~3 yrs
2 education records
Sandy Madigan education
B.S., Biochemistry
Stony Brook University
Ph.D., Genetics
Stony Brook University
FAQ
Frequently asked questions about Sandy Madigan
Quick answers generated from the profile data available on this page.
What company does Sandy Madigan work for?
Sandy Madigan works for Valora Therapeutics, Inc..
What is Sandy Madigan's role at Valora Therapeutics, Inc.?
Sandy Madigan is listed as Director at Valora Therapeutics, Inc..
What is Sandy Madigan's email address?
AeroLeads has found 1 work email signal at @enlazatx.com for Sandy Madigan at Valora Therapeutics, Inc..
What is Sandy Madigan's phone number?
AeroLeads has found 1 phone signal(s) with area code 858 for Sandy Madigan at Valora Therapeutics, Inc..
Where is Sandy Madigan based?
Sandy Madigan is based in San Diego County, California, United States while working with Valora Therapeutics, Inc..
What companies has Sandy Madigan worked for?
Sandy Madigan has worked for Valora Therapeutics, Inc., Enlaza Therapeutics, Avalon Bioventures I, Ankasa Regenerative Therapeutics, Inc., and Nerio Therapeutics, Inc..
How can I contact Sandy Madigan?
You can use AeroLeads to view verified contact signals for Sandy Madigan at Valora Therapeutics, Inc., including work email, phone, and LinkedIn data when available.
What schools did Sandy Madigan attend?
Sandy Madigan holds B.S., Biochemistry from Stony Brook University.
What skills is Sandy Madigan known for?
Sandy Madigan is listed with skills including Biotechnology, Pharmaceutical Industry, Biochemistry, Chemistry, Strategy, Drug Development, Technology Transfer, and Neuroscience.
Find 750M verified contacts
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial